18 Jan 2024
American researchers have suggested that the risk of suicidal ideation in adults using obesity and diabetes medication semaglutide is lower than those prescribed non-GLP-1 medication. The study, which is published in Nature Medicine, concludes that further research is needed to understand the perceived link.
Research Assistant in Endocrinology (University of Sheffield)
14 May 2024
BSPED Research and Innovation Award 2024 now open
03 May 2024
Nurse and Allied Health Professionals Award 2024 – applications now open
03 May 2024
Committee opportunity: Clinical Standards Officer
03 May 2024
Updated: UK Paediatric Endocrine Standards
03 May 2024